Cargando…
Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
Coronavirus disease 2019 (COVID-19) is a pandemic viral disease originated in Wuhan, China, in December 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severe form of the disease is often associated with acute respiratory distress syndrome (ARDS), and most criti...
Autores principales: | Gardin, Chiara, Ferroni, Letizia, Chachques, Juan Carlos, Zavan, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565764/ https://www.ncbi.nlm.nih.gov/pubmed/32858940 http://dx.doi.org/10.3390/jcm9092762 |
Ejemplares similares
-
Elastomeric Cardiowrap Scaffolds Functionalized with Mesenchymal Stem Cells-Derived Exosomes Induce a Positive Modulation in the Inflammatory and Wound Healing Response of Mesenchymal Stem Cell and Macrophage
por: Chachques, Juan Carlos, et al.
Publicado: (2021) -
Platelet-Derived Exosomes in Atherosclerosis
por: Gardin, Chiara, et al.
Publicado: (2022) -
Exosome in Cardiovascular Diseases: A Complex World Full of Hope
por: Bellin, Gloria, et al.
Publicado: (2019) -
Therapeutic Potential of Autologous Adipose-Derived Stem Cells for the Treatment of Liver Disease
por: Gardin, Chiara, et al.
Publicado: (2018) -
Recent Applications of Three Dimensional Printing in Cardiovascular Medicine
por: Gardin, Chiara, et al.
Publicado: (2020)